Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Enanta Pharmaceuticals Share Holder Equity 2011-2024 | ENTA

Enanta Pharmaceuticals share holder equity from 2011 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  
Enanta Pharmaceuticals Annual Share Holder Equity
(Millions of US $)
2024 $129
2023 $217
2022 $321
2021 $399
2020 $456
2019 $462
2018 $394
2017 $302
2016 $270
2015 $236
2014 $149
2013 $110
2012 $44
2011 $22
2010 $0
Enanta Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $112
2024-09-30 $129
2024-06-30 $149
2024-03-31 $166
2023-12-31 $192
2023-09-30 $217
2023-06-30 $238
2023-03-31 $269
2022-12-31 $301
2022-09-30 $321
2022-06-30 $338
2022-03-31 $359
2021-12-31 $384
2021-09-30 $399
2021-06-30 $418
2021-03-31 $436
2020-12-31 $452
2020-09-30 $456
2020-06-30 $481
2020-03-31 $486
2019-12-31 $482
2019-09-30 $462
2019-06-30 $448
2019-03-31 $436
2018-12-31 $427
2018-09-30 $394
2018-06-30 $361
2018-03-31 $333
2017-12-31 $318
2017-09-30 $302
2017-06-30 $261
2017-03-31 $266
2016-12-31 $268
2016-09-30 $270
2016-06-30 $269
2016-03-31 $266
2015-12-31 $264
2015-09-30 $236
2015-06-30 $228
2015-03-31 $224
2014-12-31 $194
2014-09-30 $149
2014-06-30 $153
2014-03-31 $102
2013-12-31 $106
2013-09-30 $110
2013-06-30 $114
2013-03-31 $118
2012-12-31 $0
2012-09-30
2012-06-30 $0
2012-03-31 $0
2011-09-30 $22
2010-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.179B $0.068B
Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.367B 31.71
Zoetis (ZTS) United States $70.491B 26.59
Takeda Pharmaceutical (TAK) Japan $44.101B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.319B 26.40
Sandoz Group AG (SDZNY) Switzerland $20.649B 0.00
Merck (MKKGY) Germany $18.495B 16.56
Astellas Pharma (ALPMY) Japan $17.499B 12.40
Summit Therapeutics (SMMT) United States $17.006B 0.00
United Therapeutics (UTHR) United States $16.401B 16.13
Shionogi (SGIOY) Japan $12.349B 12.37
Neurocrine Biosciences (NBIX) United States $11.577B 35.29
Orion OYJ (ORINY) Finland $7.681B 21.59
Madrigal Pharmaceuticals (MDGL) United States $7.656B 0.00
Corcept Therapeutics (CORT) United States $6.820B 51.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.199B 40.14
Ionis Pharmaceuticals (IONS) United States $5.197B 0.00
Grifols, S.A (GRFS) Spain $5.177B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.044B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.418B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.630B 11.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 14.57
Centessa Pharmaceuticals (CNTA) United Kingdom $2.208B 0.00
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Soleno Therapeutics (SLNO) United States $2.045B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.755B 0.00
Evotec AG (EVO) Germany $1.581B 0.00
Dyne Therapeutics (DYN) United States $1.424B 0.00
Ardelyx (ARDX) United States $1.355B 0.00
Guardian Pharmacy Services (GRDN) United States $1.273B 0.00
Indivior (INDV) United States $1.240B 5.38
ARS Pharmaceuticals (SPRY) United States $1.145B 0.00
Ocular Therapeutix (OCUL) United States $1.140B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.121B 0.00
Xencor (XNCR) United States $1.105B 0.00
Harrow (HROW) United States $1.073B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.24
Avadel Pharmaceuticals (AVDL) Ireland $0.816B 0.00
Bioventus (BVS) United States $0.807B 25.51
Cronos Group (CRON) Canada $0.742B 0.00
Relay Therapeutics (RLAY) United States $0.685B 0.00
Verve Therapeutics (VERV) United States $0.663B 0.00
USANA Health Sciences (USNA) United States $0.612B 11.34
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
OmniAb (OABI) United States $0.548B 0.00
Elite Pharmaceuticals (ELTP) United States $0.531B 0.00
KalVista Pharmaceuticals (KALV) United States $0.526B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Altimmune (ALT) United States $0.472B 0.00
Savara (SVRA) United States $0.462B 0.00
ProKidney (PROK) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.437B 5.10
Organogenesis (ORGO) United States $0.425B 0.00
Zevra Therapeutics (ZVRA) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.417B 0.00
Aldeyra Therapeutics (ALDX) United States $0.400B 0.00
Oruka Therapeutics (ORKA) United States $0.395B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 148.79
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Tourmaline Bio (TRML) United States $0.317B 0.00
CytoDyn (CYDY) United States $0.306B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.304B 0.00
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Korro Bio (KRRO) United States $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.262B 0.00
Avita Medical (RCEL) United States $0.261B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.31
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
Inhibikase Therapeutics (IKT) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.224B 0.00
4D Molecular Therapeutics (FDMT) United States $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.209B 0.00
MediWound (MDWD) Israel $0.201B 0.00
Lyell Immunopharma (LYEL) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Acrivon Therapeutics (ACRV) United States $0.182B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Inotiv (NOTV) United States $0.143B 0.00
Lexeo Therapeutics (LXEO) United States $0.133B 0.00
Cassava Sciences (SAVA) United States $0.130B 0.00
ElectroCore (ECOR) United States $0.126B 0.00
Telomir Pharmaceuticals (TELO) United States $0.124B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Galectin Therapeutics (GALT) United States $0.092B 0.00
Metagenomi (MGX) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.084B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Nutriband (NTRB) United States $0.082B 0.00
Protara Therapeutics (TARA) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.081B 0.00
FibroGen (FGEN) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.25
Karyopharm Therapeutics (KPTI) United States $0.077B 0.00
Avalo Therapeutics (AVTX) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Mural Oncology (MURA) Ireland $0.072B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Dominari Holdings (DOMH) United States $0.063B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00